Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen presenting cells. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard Therapeutics aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient.

Novo Holdings

Industrifonden

Boehringer Ingelheim Venture Fund

LU Holding

Asgard Therapeutics

Biotechnology company focused on developing drugs that target the peripheral nervous system to treat cancer and other diseases.

Cygnal Therapeutics

Biotech company specializing in developing plant-based therapeutics for various diseases, including cancer.

Neoplants

Company dedicated to the development of novel immunotherapies for cancer treatment, particularly focusing on cell reprogramming techniques.

Xios Therapeutics

Asgard Therapeutics is a Swedish private biotech company that explores direct cell reprogramming technologies to develop cancer immunotherapies. The company's lead program, AT-108, is designed to initiate immune responses mediated by professional antigen presenting cells, overcoming logistical and manufacturing hurdles of conventional cell-based therapies.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

logo

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	Mar 4, 2024 1:06 AM	f746a9e5
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 4, 2024 1:06 AM	3cd49cff
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
peers	general
news basic	general	Mar 4, 2024 1:06 AM	808674b3
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
logo	meta
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:ASGARDTHX

Asgard Therapeutics